Filing Flows › TriSalus Life Sciences (TLSI) › Stock forecast & fair value
TriSalus Life Sciences (TLSI) stock forecast and price target
TriSalus Life Sciences (TLSI) trades at $3.25. 5 analysts' median price target is $11.00 (+238%), from $7.00 to $14.00.
TriSalus Life Sciences' latest quarter
TriSalus Life Sciences, Q2 2026: revenue $11.4M (+2% year over year), operating margin -86.0%, net loss $9.2M, operating cash flow −$10.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for TLSI stock?
The median of 5 analysts' 12-month targets is $11.00, +238% from $3.25; the range is $7.00 to $14.00. The average rating is none.
Does TriSalus Life Sciences usually beat earnings estimates?
It beat the consensus EPS estimate in 33% of the quarters on record.
Is TLSI stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.